KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-Current Debt: 2009-2023

Historic Non-Current Debt for Exact Sciences (EXAS) over the last 13 years, with Mar 2023 value amounting to $50.0 million.

  • Exact Sciences' Non-Current Debt was N/A to $50.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $50.0 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2022, which is N/A change from last year.
  • Per Exact Sciences' latest filing, its Non-Current Debt stood at $50.0 million for Q1 2023, which was down 0.00% from $50.0 million recorded in Q4 2022.
  • Exact Sciences' 5-year Non-Current Debt high stood at $50.0 million for Q2 2022, and its period low was $21.4 million during Q3 2021.
  • Its 3-year average for Non-Current Debt is $37.9 million, with a median of $50.0 million in 2023.
  • Per our database at Business Quant, Exact Sciences' Non-Current Debt surged by 2,682.35% in 2019 and then fell by 7.03% in 2020.
  • Over the past 5 years, Exact Sciences' Non-Current Debt (Quarterly) stood at $24.0 million in 2019, then dropped by 7.03% to $22.3 million in 2020, then decreased by 5.32% to $21.4 million in 2021, then spiked by 133.23% to $50.0 million in 2022, then reached $50.0 million in 2023.
  • Its Non-Current Debt was $50.0 million in Q1 2023, compared to $50.0 million in Q4 2022 and $50.0 million in Q3 2022.